RT Journal Article
T1 Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
A1 Reolid, Alejandra
A1 Armesto, Susana
A1 Sahuquillo-Torralba, Antonio
A1 Torres, Tiago
A1 Feltes, Rosa
A1 Vilarrasa, Eva
A1 Belinchón, Isabel
A1 Cueva, Pablo de la
A1 Rodríguez, Lourdes
A1 Romero-Maté, Alberto
A1 Vidal, David
A1 Coto-Segura, Pablo
A1 Herrera-Acosta, Enrique
A1 Riera-Monroig, Josep
A1 Salgado, Laura
A1 Llamas-Velasco, Mar
A1 Daudén, Esteban
K1 daily practice setting
K1 palmoplantar psoriasis
K1 palmoplantar pustular psoriasis
K1 secukinumab
YR 2022
FD 2022-05-28
LK http://hdl.handle.net/10668/22281
UL http://hdl.handle.net/10668/22281
LA en
DS RISalud
RD Apr 7, 2025